EIT Health’s Innovation Call
Share this opportunity
Apply before 13 January 2027 for the EIT Health’s Innovation Validation Call 2027.
EIT supports innovative digital and AI–powered medical technologies that are ready for real-world clinical validation and are approaching market launch. This call addresses the funding gap for solutions that need to run clinical studies and collect evidence to demonstrate safety and efficacy, apply for regulatory approval and prepare for market commercialisation.
Consortia of at least two organisations from different countries representing at least two sides of the Knowledge Triangle (industry, research, education). A commercialising company must lead the project. Eligible solutions must be digital or AI-enabled medical devices (MDR/IVDR) at Innovation Maturity Level (IML) 6, aiming to reach IML 7 by project end. Please refer to EIT Health’s Healthcare Innovation Cycle Framework for more information on the required Innovation Maturity Level for this call.
EIT Health will fund up to 50% of the total project budget, up to a total grant funding amount of €850,000 per project.
The commercialising entity must sign a Financial Sustainability Contribution Agreement and, in the case that it is a micro or small enterprise, must receive €400,000–€500,000 of the grant.
⏰ Application Deadline: 13 January 2027 | ➡️ Information